CAMP
CAMP4 Therapeutics Corporation
There isn't enough reported data to score CAMP yet.
HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
CAMP Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Under pressure | |
| Weak |
CAMP's profitability, cash flow and balance sheet are currently under pressure. There isn't enough data to rate its revenue.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
CAMP PE Valuation
CAMP has no meaningful PE right now: it lost money over the past year.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
CAMP Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect CAMP's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
CAMP Earnings Per Share
CAMP lost $2.13 per share over the past year, a bigger loss than the year before.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has the edge over CAMP in the latest year-over-year earnings comparison.
CAMP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.9M | +139% |
| Q2 2026 | $1.8M | +19% |
| Q1 2026 | $1.3M | +51% |
| Q3 2023 | $350K | -100% |
| Q2 2023 | $70.9M | +9.5% |
| Q1 2023 | $78.5M | +15% |
| Q4 2022 | $78.9M | +15% |
| Q3 2022 | $72.8M | -7.8% |
CAMP's revenue is recovering but still below its 2020 peak: $2M last quarter, up 139% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -739% | +978 points |
| Q2 2026 | -752% | +118 points |
| Q1 2026 | -1010% | +517 points |
| Q4 2025 | -3671% | N/A |
| Q3 2025 | -1717% | N/A |
| Q2 2025 | -870% | N/A |
| Q1 2025 | -1527% | N/A |
| Q3 2023 | -3525% | -3518 points |
CAMP's operating margin was −739% last quarter, up 978 points from the same quarter a year ago.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over CAMP on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over CAMP on profitability, with a higher operating margin.
CAMP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$8.9M | +$2.3M |
| Q2 2026 | -$12.8M | -$2.5M |
| Q1 2026 | -$11M | +$3.6M |
| Q4 2025 | $6.3M | +$17.8M |
| Q2 2025 | -$10.3M | +$3.3M |
| Q1 2025 | -$14.6M | -$3.4M |
| Q4 2024 | -$11.6M | +$475K |
| Q2 2024 | -$13.6M | -$10.5M |
CAMP has burned cash in most quarters: −$26M over the past year, against −$48M the year before.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
HIMS has the edge over CAMP on cash generation, producing positive trailing cash flow while its opponent burns cash.
CAMP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +36% | +21M shares |
| 1 year | +292% | +58.8M shares |
| 3 years | +119% | +42.9M shares |
CAMP has 79M diluted shares, up 292% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over CAMP on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
CAMP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 25.3x | High |
| Q2 2021 | 14.1x | High |
| Q1 2021 | 8.2x | High |
| Q4 2020 | 15.9x | High |
| Q3 2020 | 16.1x | High |
| Q2 2020 | 9.9x | High |
| Q1 2020 | 13.2x | High |
CAMP's net debt is more than 20 years of its operating earnings (EBITDA), up from 16 years a year ago.
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
CAMP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 50.5 | Neutral |
| Stochastic | 35.4 | Neutral |
CAMP's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
CAMP PE vs Healthcare Sector
CAMP has no meaningful PE right now: it lost money over the past year.
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
CAMP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.78 | 8.2% above |
| 20 week MA | $4.03 | 1.5% above |
| 50 week MA | $4.39 | 6.8% below |
| 100 week MA | $3.75 | 9.1% above |
CAMP has stronger trend alignment. CAMP is above 3 of 4 weekly averages versus HIMS above 0 of 5.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
CAMP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $10.7 | $5.43 | -49% |
| 2025 | $5.43 | $5.96 | +9.8% |
| 2026 YTD | $5.96 | $4.09 | -31% |
CAMP has the edge over HIMS on returns for 2026, with the stronger performance.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS's yearly returns have swung widely, from +198% in 2024 to −56% in 2021. It's down 42% so far in 2026.